{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:47Z","timestamp":1790222867366,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["95141"],"award-info":[{"award-number":["95141"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215596","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:25:46Z","timestamp":1556889946000},"page":"e0215596","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-5833","authenticated-orcid":true,"given":"Sabrina","family":"Cossais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Schwarzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Larrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Canva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Deuffic-Burban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1478-3231.2006.01331.x","article-title":"Quality of life in hepatitis C","volume":"26","author":"E Strauss","year":"2006","journal-title":"Liver Int. sept"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/1471-2458-12-672","article-title":"The ongoing impacts of hepatitis c\u2014a systematic narrative review of the literature","volume":"12","author":"ER Miller","year":"2012","journal-title":"BMC Public Health"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment*","volume":"8","author":"HH Thein","year":"2007","journal-title":"HIV Med"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.3310\/hta10210","article-title":"Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation","author":"M Wright","year":"2006"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10198-005-0280-7","article-title":"Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon \u03b1-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany","volume":"6","author":"U Siebert","year":"2005","journal-title":"Eur J Health Econ"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1053\/j.gastro.2012.05.054","article-title":"Predicted effects of treatment for HCV infection vary among European countries","volume":"143","author":"S Deuffic-Burban","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/lt.21376","article-title":"Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index","volume":"14","author":"AA Dan","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1572-0241.2005.40976.x","article-title":"Estimation of utilities for chronic hepatitis C from SF-36 scores","volume":"100","author":"H-H Thein","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s10620-012-2233-1","article-title":"The burden of untreated hepatitis C virus infection: a US patients\u2019 perspective","volume":"57","author":"AC El Khoury","year":"2012","journal-title":"Dig Dis Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-230X-13-16","article-title":"The burden of hepatitis C in Europe from the patients\u2019 perspective: a survey in 5 countries","volume":"13","author":"J Vietri","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1016\/S0168-8278(15)30950-8","article-title":"P0747: Health related quality of life and utility values in chronic hepatitis C patients: A cross-sectional study in France, the Uk and Germany","volume":"62","author":"S Pol","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.20014","article-title":"Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection","volume":"39","author":"O Dalgard","year":"2004","journal-title":"Hepatology. janv"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1525-1497.2003.20826.x","article-title":"They treated me like a leper \u00bb. Stigmatization and the quality of life of patients with hepatitis C","volume":"18","author":"S Zickmund","year":"2003","journal-title":"J Gen Intern Med"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1572-0241.2003.07332.x","article-title":"Health-state utilities and quality of life in hepatitis C patients","volume":"98","author":"CAKY Chong","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1478-3231.2008.01865.x","article-title":"Does cirrhosis affect quality of life in hepatitis C virus-infected patients?","volume":"29","author":"PC Hsu","year":"2009","journal-title":"Liver Int"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1440-1746.2011.06813.x","article-title":"Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection: Quality of life in HCV infection","volume":"27","author":"PC Hsu","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.20468","article-title":"Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt","volume":"40","author":"M Schwarzinger","year":"2004","journal-title":"Hepatol Baltim Md. d\u00e9c"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.510300504","article-title":"The impact of diagnosis of hepatitis C virus on quality of life","volume":"30","author":"AJ Rodger","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2010.04460.x","article-title":"Barriers to accessing care in patients with chronic hepatitis C: the impact of depression","volume":"32","author":"DM Evon","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref20","first-page":"370","article-title":"Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study","volume":"23","author":"Z Pavlovi\u0107","year":"2011","journal-title":"Psychiatr Danub"},{"issue":"140","key":"ref21","first-page":"55","article-title":"A technique for the measurement of attitudes","volume":"22","author":"R Likert","year":"1932","journal-title":"Arch Psychol"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism. The CAGE questionnaire","volume":"252","author":"JA Ewing","year":"1984","journal-title":"JAMA"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10198-011-0351-x","article-title":"Valuing EQ-5D using Time Trade-Off in France","volume":"14","author":"J Chevalier","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"R Brooks","year":"1996","journal-title":"Health policy"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1008960710415","article-title":"Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C","volume":"9","author":"L Kleinman","year":"2000","journal-title":"Quality of Life Research"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1572-0241.2001.04133.x","article-title":"Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C","volume":"96","author":"KB Hussain","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00535-013-0781-6","article-title":"Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance","volume":"49","author":"T Kuwashiro","year":"2013","journal-title":"J Gastroenterol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11255-009-9576-3","article-title":"Quality of life in hemodialysis patients: hepatitis C virus infection makes sense","volume":"41","author":"B Afsar","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jvh.12095","article-title":"Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV\/HIV co-infected adults","volume":"20","author":"EY Chen","year":"2013","journal-title":"J Viral Hepat"},{"key":"ref30","article-title":"Prise en charge des personnes infect\u00e9es par les virus de l\u2019h\u00e9patite B ou de l\u2019h\u00e9patite C: rapport de recommandations","author":"D Dhumeaux","year":"2014","journal-title":"Prise en charge des personnes infect\u00e9es par les virus de l\u2019h\u00e9patite B ou de l\u2019h\u00e9patite C: rapport de recommandations"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","article-title":"Measurement of health state utilities for economic appraisal","volume":"5","author":"GW Torrance","year":"1986","journal-title":"J Health Econ. mars"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10198-008-0097-2","article-title":"SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility","volume":"10","author":"R Grieve","year":"2009","journal-title":"Eur J Health Econ HEPAC Health Econ Prev Care"},{"key":"ref33","article-title":"Mesure de l\u2019utilit\u00e9 attach\u00e9e aux \u00e9tats de sant\u00e9: valorisation de l\u2019index d\u2019utilit\u00e9 EQ-5D et \u00e9volution de l\u2019\u00e9chelle actuelle en France","author":"J Chevalier","year":"2010","journal-title":"Measurement of health state utilities: Valuation of the EQ-5D and improvement of the descriptive system in the French context"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:41:49Z","timestamp":1588977709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215596"}},"subtitle":[],"editor":[{"given":"Florian","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215596","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735694677.793560023","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]}}}